$1.07 Billion is the total value of Vivo Capital, LLC's 46 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SNSS | Exit | Sunesis Pharmaceuticals, Inc. | $0 | – | -99,441 | -100.0% | -0.01% | – |
| BPMX | Exit | BioPharmX Corporation | $0 | – | -16,128,515 | -100.0% | -0.14% | – |
| TRVN | Exit | Trevena, Inc. | $0 | – | -1,233,677 | -100.0% | -0.19% | – |
| ZLAB | Exit | Zai Lab Limitedadr | $0 | – | -71,595 | -100.0% | -0.21% | – |
| SBBP | Exit | Strongbridge Biopharma plc | $0 | – | -914,062 | -100.0% | -0.45% | – |
| GNCA | Exit | Genocea Biosciences Inc | $0 | – | -7,811,206 | -100.0% | -0.46% | – |
| QURE | Exit | Uniqure NV | $0 | – | -180,336 | -100.0% | -1.07% | – |
| ACER | Exit | Acer Therapeutics Inc | $0 | – | -579,051 | -100.0% | -1.40% | – |
| BHVN | Exit | Biohaven Pharmaceutical Holding Company Ltd | $0 | – | -504,980 | -100.0% | -2.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
| CODEXIS INC | 29 | Q3 2023 | 8.0% |
| ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
| KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
| Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
| AMYRIS INC | 23 | Q3 2023 | 8.8% |
| EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
| Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
| Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
| HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-22 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.